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Abstract 
The current state of the art in medical genetics is to identify and classify the functional (deleterious) or non-functional 
(neutral) single amino acid substitutions (SAPs), also known as non-synonymous SNPs (nsSNPs). The primary goal is to 
elucidate the mechanisms through which functional SAPs exert their effects, and ultimately interrogating this infor-
mation for association with complex phenotypes. This work focuses on coagulation factors involved in the coagula-
tion cascade pathway which plays a vital role in the maintenance of homeostasis in the human system. We developed 
an integrated coagulation variation database, CoagVDb, which makes use of the biological information from various 
public databases such as NCBI, OMIM, UniProt, PDB and SAPs (rsIDs/variant). CoagVDb enriched with computational 
prediction scores classify SAPs as either deleterious or tolerated. Also, various other properties are incorporated such 
as amino acid composition, secondary structure elements, solvent accessibility, ordered/disordered regions, conserva-
tion, and the presence of disulfide bonds. This specialized database provides integration of various prediction scores 
from different computational methods along with gene, protein, and disease information. We hope our database 
will act as a useful reference resource for hematologists to reveal protein structure–function relationship and disease 
genotype–phenotype correlation.
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Background
The mechanism of blood coagulation plays a central role 
in the maintenance of homeostasis in the human system. 
Three major interrelated constituents of the hemostatic 
pathway include platelets, endothelium, and coagula-
tion proteins which maintain fluidity of the blood in the 
normal state and also arrests bleeding by blood clot for-
mation. The coagulation system is necessary for contain-
ing the blood loss from a vascular injury due to trauma 
results in fibrin formation and platelet activation. Blood 
coagulation factors function in an incessant cascade to 
achieve one central goal, which is the arrest of bleeding. 
Even miniature change in the structure or concentration 
of these factors in the blood can disrupt the entire system 
of blood clotting. A defect in the normal blood clotting 
mechanism (reduced or absence of coagulation proteins) 
leads to several types of bleeding disorders which are 
highly prevalent in global populations (Additional file 1: 
Table S1). Among them, Von Willebrand disease is the 
most common inherited bleeding disorder that affects 
nearly 1% of the world’s population [1]. Coagulation sys-
tem in human is initiated by two different mechanisms 
i.e. the process of contact activation (intrinsic) and the 
action of tissue factor (extrinsic). These two separate 
pathways converge and activate the final common path-
way leading to fibrin formation. The two pathways occur 
in a cascade involving the action of twelve different fac-
tors each working to activate the successive factors.
A recent development in high throughput screening 
methods and cost reduction genotyping has generated a 
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tremendous amount of information about the existence 
of an association between single amino acid polymor-
phisms (SAPs) and bleeding and coagulation disorders. 
These advancements have yielded a considerable quantity 
of information especially on genomic variant data (SAPs) 
and revolutionized the current field of biology and medi-
cine, i.e., personalized medicine. The current state of art 
in clinical genetics is to identify and classify the functional 
(deleterious) or non-functional (neutral) SAPs in diseases, 
to elucidate the mechanisms through which functional 
SAPs exert their effects [2, 3]. SAPs also known as non-
synonymous SNPs (nsSNPs); result in a change of amino 
acid sequence that can alter the protein function. SAPs 
can be categorized into harmful (deleterious) and neutral. 
Most of the SAPs are not harmful [4]. Half of all genetic 
changes related to human diseases are associated to SAPs 
[5]. Therefore, discriminating the harmful from neutral 
ones, from a pool of millions of SAPs, remains as a con-
siderable challenge in mutational research [2, 3, 6, 7]. This 
categorization can assist in better understanding of the 
genotype/phenotype relationship and drug response to 
disease. Several large repository databases are made avail-
able through World Wide Web in providing information 
regarding millions of SAPs such as dbSNP [8], Ensembl 
[9] and UniProt [10]. Scientists are facing a major chal-
lenge in the identification, functional characterization, 
and the association between SAPs and disease susceptibil-
ity in the large-scale analysis.
Recent technological advances resulted in the accu-
mulation of an extensive amount of information on each 
component of this complex coagulation mechanism. 
An increase in the occurrence of heritable deficiencies 
of the blood clotting factors has led to development of 
few reliable sources, such as ClotBase (http://www.clot-
base.bicnirrh.res.in/) [11], Factor VIII variation database 
(http://www.factorviii-db.org/) [12], factor IX  variation 
database (http://www.factorix.org/) [13], and VWFDb 
(http://www.vwf.group.shef.ac.uk/) [14] to provide infor-
mation on the sequence, structure and phenotypes of 
various coagulation proteins. In this paper, we propose a 
user-friendly and freely accessible interface Coagulation 
Variation Database (CoagVDb), which allows the user to 
collect the sequence and variant information regarding 
the proteins involved in coagulation cascade pathway. The 
primary goal of the constructed CoagVDb is intended to 
integrate most reliable biological information about the 
genes, proteins and variants involved in coagulation cas-
cade pathway. Moreover, we captured the computational 
prediction scores of SIFT [15], PolyPhen 2 [16], I-Mutant 
3 [17], fathmm [18], Align GVGD [19], PhD-SNP [20], 
SNPs&GO [21] and SNAP [22] to classify SAPs as del-
eterious/harmful or tolerated/neutral. Development of 
new techniques and production of efficient drugs for use 
against bleeding disorders requires information from 
protein structure as well. The information derived from 
primary sequence properties (physicochemical prop-
erties of the amino acids) is essential for exploring the 
effects of each SAP on protein structure and function. 
Based on this, we have incorporated information about 
three dimensional structures, amino acid composition, 
conserved regions, disulfide bonds, ordered/disordered 
regions, secondary structure elements, and solvent acces-
sibility in the constructed database. Studying the SAPs 
and their effects along with sequence analysis informa-
tion is often crucial for understanding the effects on pro-
tein functionality and biochemical reactions. Analyzing 
and understanding structure–function relation of the 
associated deleterious SAPs for a particular coagulation 
factor protein will open new possibilities for diagnostic 
and therapeutic efforts.
To best of our knowledge, there is no comprehen-
sive database capturing the protein sequence, structure 
and SAPs information along with the in silico predic-
tion scores for coagulation factors in one platform. The 
goal of this project is aimed to design and implement a 
freely accessible web interface CoagVDb that collates the 
genomic information in a curated, yearly updated, con-
cise and well-structured manner. We hope this platform 
will help researchers in understanding the genotype-
phenotype relationship, which is the first and foremost 
important step in drug research and development. This 





The CoagVDb provides access to genomic informa-
tion related to coagulation factors. Information consists 
of HGNC gene name, gene symbol, gene ID, organism 
source, taxonomy identification, chromosome number, 
chromosome location, chromosome sequence (NC), and 
NCBI map viewer. Gene related information present in 
other databases such as OMIM, Ensembl, and UniProtKB 
were also interlinked. This allows the user to search for 
Ensembl gene ID, HUGO gene name or HGNC gene ID, 
Entrez Gene ID, and OMIM gene ID. The gene infor-
mation such as the DNA sequence and chromosomal 
location was obtained from NCBI. Epigenetic informa-
tion such as histone modifications, chemical changes in 
DNA, chromatin accessibility, gene expression and small 
RNA expression is available in the epigenomics section 
of the NCBI database. Further, to enrich the available 
information on the gene sequence, the CoagVDb pro-
vides integration with the NCBI MapViewer in the form 
of hyperlinks. Moreover, the database forms a simple 
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network between various other databases and informa-
tion sources through conveniently openable links in a new 
tab. Literature information on the gene coding the factors, 
properties of the proteins involved in the mechanism, 
and the consequences of variations that result in disease 
phenotypes were obtained from published articles avail-
able in PubMed, OMIM and UniProtKB and referred with 
PubMed ID. Some of the information integrated with the 
other database includes HGNC, Entrez, Ensembl, UCSC, 
OMIM, UniProtKB, UniGene, RefSeq, and KEGG.
Search by variant name
To display the records of 3187 SAPs, we designed user-
friendly web interface in CoagVDb. To increase the accu-
racy of SAPs annotation, we initially collected the SAPs 
related information from dbSNP and overlapped with the 
variant information from UniProt. We listed the SAPs 
with reference links to rsIDs/variants, amino acid posi-
tion, allele change, contig position, protein ID (FASTA 
sequence identification number (NP) and UniProt 
sequence number). The amino acid change in each vari-
ant is represented by wild and new residue after mutation 
(Single letter amino acid code) e.g. WT+POS+NEW.
Protein information
Information related to the protein can be accessed in two 
ways; sequence and structure information.
Sequence information
This section of the database entry contains information 
about the protein sequence that integrates sequence 
analysis information from various computational meth-
ods. The sequence information includes sequence length, 
amino acid composition, solvent accessibility, secondary 
structural elements, ordered/disordered regions, cysteine 
residue location, disulfide bond formation and conserva-
tion score provided in the form of a table.
Amino acid composition
Amino acid sequence composition analysis can provide 
the most direct information about the functional muta-
tion sites of the protein. Recent studies have explored the 
occurrence of various amino acids along with their bio-
physical characteristic in the native and mutant state of 
numerous proteins [23–25]. We calculated the compo-
sition of each amino acid in corresponding coagulation 
factor protein sequence by Statistical Analysis of Protein 
Sequences [26]. For this analysis, we submitted the indi-
vidual protein FASTA sequence as an input file.
Secondary structure analysis and solvent accessibility
We analyzed the occurrence, location and distribution 
of secondary structural elements, α-helices, β-strands, 
turns, and bends. Amino acids distributions among these 
elements were considered to be the essential structural 
components of protein scaffolds. Secondary structure 
and solvent accessible area of each amino acid in the pro-
tein sequence was calculated using NetSurfP ver. 1.1 [27]. 
The secondary structure elements were represented as H: 
Alpha-helix; G: 3-10-Helix; I: Pi-helix (extremely rare); 
E: Extended strand; B: Beta-bridge; T: turn; S: Bend; and 
C: The Rest. Solvent accessible area of each amino acid is 
classified as buried and exposed and represented in red 
and black color, respectively.
Disordered residues
The disordered region in a protein sequence is charac-
terized by the presence of enriched polar and charged 
amino acids with low percentage of hydrophobic amino 
acids [28]. DISpro [29] was utilized to predict the prob-
ability of each amino acid residue to be ordered or dis-
ordered.  The residues were designated as O-Ordered; 
D-Disordered in the output file.
Cysteine residues and disulfide bonds
Studies have highlighted the importance of Cys residues 
and disulfide bonds in protein folding [30]. Amino acid 
residue change to (or) from Cys is most likely to desta-
bilize a protein structure. Taking into consideration, we 
extended our analysis of sequence information by the 
application of DIpro [31] to predict disulfide bonds and 
estimate the number of disulfide bonds in a given protein 
sequence.
Sequence conservation
Disease-causing SAPs often reside in highly conserved 
positions. Assessment of non-neutral SAPs is primarily 
based on phylogenetic information (i.e. correlation with 
residue conservation) extended to an individual scale 
with structural approaches. A multiple sequence align-
ment of the homologous sequence reveals the position 
at which amino acids are conserved throughout evolu-
tionary time. These positions can be critical for protein 
function [32]. Initially, we performed multiple sequence 
alignments (MSA) using multiple sequence compari-
son by log-expectation (MUSCLE), a web-based tool to 
align multiple sequences from several vertebrate spe-
cies including humans [33]. We searched the protein 
sequence of coagulation factors against a sequence data-
base to find sequences of homologous proteins. The 
importance of a residue for maintaining the structure and 
function of a protein can usually be inferred based on the 
conservation pattern. ConSurf [34] quantifies the degree 
of conservation at each aligned position to represent 
localized evolution. This server provides the evolutionary 
conservation profiles of protein or nucleic acid sequence 
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or structure by first identifying the conserved positions 
using MSA and then calculates the evolutionary conser-
vation rate using an empirical Bayesian inference.
Structure information
Data on the available three-dimensional (3D) structure 
coordinates of coagulation factor proteins were listed in 
this database section. Experimentally determined struc-
tures either by X-ray or NMR were obtained from the 
protein data bank (PDB) [35]. In addition, we incorpo-
rated 3D structure resolution, chain type, and amino acid 
residue position information.
Prediction tools
We predicted the functional effect of each SAP as path-
ogenic/deleterious or neutral/tolerated by using compu-
tational prediction methods such as SIFT [15], PolyPhen 
2 [16], I-Mutant 3 [17], fathmm [18], Align GVGD [19], 
PhD-SNP [20], SNPs&GO [21] and SNAP [22]. The 
methods mentioned above utilize different input fea-
tures in making their predictions, but the ultimate goal 
is to discriminate deleterious or functional SAPs from 
neutral ones. We submitted either gene identification 
(GI) number or FASTA sequence or Swiss-Prot protein 
code, substitution position (sequence residue number) 
and native or wild type residue (Single letter amino acid 
code) and new residue after mutation as mutant (single 
letter amino acid code) e.g., WT+POS+NEW as input. 
Integrating the prediction scores of sequence (SIFT, 
PhD-SNP, Align GVGD, and fathmm) and combination 
of sequence and or structure based (PolyPhen-2, SNAP, 
SNPs&GO and I-Mutant 3) computational methods 
may provide wider coverage and more accurate pre-
dictions in the study of SAPs. Above utilized methods 
derive their information from the multiple sequence 
alignment of the homologous sequences to give more 
information about the extent of conservation based on 
the input generated internally (SIFT & SNPs&GO) or 
submitted by the user (PolyPhen-2 & Align GVGD). 
Detailed information regarding the prediction scores 
of the above eight computational methods is described 
in Additional file  1: Table S2. We have introduced a 
ranking scheme to prioritize the variants based on the 
prediction score designated as ‘deleterious’ obtained 
from the above eight computational methods. Variants/
rsIDs showing all 8 tool prediction score as deleterious 
will be ranked as ‘1’, variants showing 6–7 tools predic-
tion score as deleterious will be ranked as ‘2’, variants 
showing 4–5 tools prediction score as deleterious will 
be ranked as ‘3’, variants showing 2–3 tools predic-
tion score as deleterious will be ranked as ‘4’, variants 
showing 0–1 tool prediction score as deleterious will be 
ranked as ‘5’ respectively (Figure 1).
Web interface
The freely accessible CoagVDb allow users to perform 
‘quick search’ using keyword gene symbol, variant/rsIDs 
in the left navigation bar. We have listed out the addi-
tional information regarding the genes, disease, diag-
nosis, FASTA sequence, download, and site map of 29 
coagulation proteins. Gene button module allows the 
user to provide a direct link to 29 gene information. Dis-
ease button allows user to access the useful information 
such as disease name, inheritance pattern, OMIM ID, 
disease classification (primary and secondary hemosta-
sis) and occurrence (most common, less frequent and 
extremely rare). Diagnosis button provides informa-
tion about the preliminary screening protocol, labora-
tory evaluation of coagulation disorders of common and 
multiple pathways and diagnosis of coagulation disor-
ders using preliminary screening tests. Download button 
allow the user to download the gene, protein, variant, tool 
prediction related information of 29 coagulation protein 
in.xls format. Lastly site map was created to provide an 
overview of the database which allow user to access and 
navigate in a friendly manner. In the main web inter-
face section ‘home’, we have provided the diagrammatic 
representation of coagulation cascade pathway which 
illustrates the involvement of various factors in intrin-
sic, extrinsic and common pathways. The active form of 
coagulation factors is represented in the grey color oval 
button with a hyperlink, whereas orange, violet, green 
color oval button represents the inactive form of fac-
tors in intrinsic, extrinsic and common pathways. The 
main taskbar “search” button allows the user to pick up 
gene, variant, sequence, structure, and prediction tools 
information. Clicking on the information tab enables the 
user to display the detailed information page of the cor-
responding entries with a hyperlink in the browser. In 
order to make an easy way to jump between sections, we 
have provided the all the information regarding a gene 
i.e. variant, sequence, structure, and prediction tools 
information on the same page. In addition, we have pro-
vided ‘Resource’ module which allows user to cross-link 
to other databases (NCBI, OMIM, HGMD, etc.), compu-
tational prediction methods (SIFT, PolyPhen2, PHD-SNP 
etc.) and related links (related coagulation factor data-
bases (ClotBase [11], Factor IX Mutation Database [36] 
etc.) with their corresponding hyperlinks. Lastly, help 
button provides guidance to user how to access different 
search fields using PLAU as an example.
Resources
In the navigation bar resource section, we have listed 
database, tool information, and their related links. Data-
base tab lists out the biological database source which 
is available online along with their hyperlinks. Tool 
Page 5 of 8Ali et al. Biol Res  (2015) 48:35 
information tab provides the detailed information about 
the computational methods which are employed to clas-
sify SAPs. Lastly, related links tab contains the informa-
tion about the existing databases related to coagulation 
factors.
Comparison to existing databases
To the best of our knowledge related to coagulation fac-
tors, only a few databases are available online during the 
construction of this database. Most of the existing online 
available databases ClotBase [11], Factor VIII variation 
database [12], factor IX variation database [13], VWFDb 
[14], and FXI Deficiency Mutation Database [37] are 
centered towards individual coagulation factors. In com-
parison, ClotBase [11] offers compiled data on the blood 
coagulation proteins. Information regarding the change 
in amino acid sequence, evolutionary conserved regions, 
mutations, and other curated data has been made avail-
able to this database. Von Willebrand Factor database 
or VWFdb is an online database that centers on von 
Willebrand disease. This database primarily contains 
sequence variants data and provides additional resources 
to understand the disease association. The Haemophilia 
A Mutation, search, test, and resource site (HAMSTeRS) 
was initiated in 1996. This contains information on fac-
tor VIII of blood coagulation and extensive data on the 
point mutations, insertions, and deletions. Data obtained 
from computational analysis of the mutations and struc-
tural studies have also been included. Now this has been 
shifted to UCL  F8  DB (HADB/HAMSTeRS). CoagMDB 
is a database that carries information on five serine pro-
tease factors of the blood coagulation pathway. This 
interactive database incorporates all five factors fac-
tor II, factor VII, factor IX, factor X and protein C and 
their corresponding mutational information. The muta-
tions were correlated with experimentally quantifiable 
phenotypes with the help of data available on consensus 
domain structures. The FXI Deficiency Mutation Data-
base was created to concentrate the information available 
regarding the mutations in the gene sequence of factor 
XI.
In comparison to the databases mentioned above, 
the information available in CoagVDb spans out in fol-











































All 8 tools 6-7 tools 4-5 tools 2-3 tools 0-1 tool
Rank 1 Rank 2 Rank 3 Rank 4 Rank 5
Ranking scheme based on 
deleterious prediction scores
Figure 1 Coagulation variation database (CoagVDb) construction.
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coagulation factors along with gene/protein and rsIDs/
variant information. It links HGNC, Entrez, Ensembl, 
UCSC, OMIM, UniProtKB, UniGene, RefSeq, and 
KEGG. Secondly, we have provided sequence informa-
tion (amino acid sequence length, composition, solvent 
accessibility, secondary structural elements, ordered/
disordered regions, cysteine residue location, disulphide 
bond formation and conservation) along with available 
3D structure information (X-ray or NMR). This feature 
will allow users to access the physicochemical charac-
teristic of each native and mutant amino acid. Third, we 
have included pathogenicity prediction scores for each 
SAP using various sequence and structure based predic-
tion methods will allow the user to discriminate deleteri-
ous SAPs from neutral ones from a pool. Lastly, we have 
applied a ranking scheme to prioritize the functional 
SAPs based on deleterious scores obtained from the com-
putational prediction methods. This added advantage 
over the existing databases efficiently helps  to identify 
and classify the SAPs that alter the function of coagula-
tion factor proteins. Moreover, rich content made avail-
able in CoagVDb is easy to use and interpret by any end 
user.
Discussion
A recent survey states that SAPs constitute more than 
50% of the known mutations are involved in human 
individual Mendelian diseases [38]. It is also estimated 
approximately that each may hold 24,000–40,000 SAPs 
and most of them found to be deleterious [39]. Most of 
the SAPs lack experimental annotation of their func-
tional impact. Differentiating functional prediction of 
an SAP being deleterious (significant phenotypic conse-
quences) from neutral one (without phenotypic change) 
is of prime importance in understanding the genetic 
basis of the disease. This discrimination and prediction 
of the phenotypic effect of a genomic pool remains as a 
major challenge for experimental biologists due to labori-
ous and time-consuming process involved. Alternatively, 
computational methods can discriminate functionally 
deleterious SAPs from non-deleterious ones with sig-
nificant accuracy while being relatively fast. They classify 
the SAPs as deleterious or neutral based on the physico-
chemical properties of amino acids in sequence or struc-
ture context. Numerous methods have been proposed 
online and classified as sequence-based or structure-
based methods. They utilize evolutionary sequence con-
servation, structure information, and the combination of 
sequence and structure information in making their pre-
dictions. Sequence-based methods (SIFT, fathmm, and 
PhD-SNP) have a added advantage over the structure-
based methods (PolyPhen 2, SNAP, and SNPs&GO) in 
making their predictions, as they can be applied to any 
proteins with known relatives. Similarly, structure-based 
methods incorporate the physicochemical properties of 
amino acids along with known 3D structures to make 
their predictions. Because of the usage of different algo-
rithms in making their prediction, each method has its 
strength and weakness. The results obtained from the 
comparative studies [40–45] indicate that the use of com-
bination of prediction methods with sequence and struc-
ture information may provide wider coverage and more 
accurate way for SAP analysis. In this context, we incor-
porated the prediction scores of well-known sequence 
and structure-based methods in CoagVDb. The unique-
ness of the developed database is represented by three 
level of data integration. First is to connect all the related 
biological information such as a gene, protein, variant 
(SAPs) and published literature of the coagulation fac-
tors that are involved in the complex coagulation cas-
cade pathway. Second is to provide primary sequence and 
structure information. Third is to identify and discrimi-
nate functionally deleterious SAPs from neutral ones in 
coagulation cascade proteins. This will provide a way to 
filter the SAPs, thereby leading to a better selection of 
SAPs to be included in further genotyping.
Conclusion and future update
We conclude that this constructed database will be of 
great aid to clinicians in applying a biological prioritiza-
tion strategy when selecting an SAP for further analysis. 
This will allow building relationship between the disease-
related mutations and structural properties of proteins. 
The inclusion of online submission facility will keep the 
database up-to-date. In future, we would like to expand 
the database by including a comprehensive information 
on 3′ and 5′ UTR SNP information along with sequence 
accession numbers (NM). In this step, we will character-
ize the functional significance of each regulatory SNP by 
using various computational methods. Lastly, we will also 
include the 3D model of the mutant proteins.
Methods
The primary objective of CoagVDb is to combine vari-
ous biological information components that are involved 
in blood coagulation cascade. CoagVDb hosts a colossal 
amount of useful data on coagulation factors and their 
associated variants. In this section, we describe the entire 
process of database construction, data generation, and 
structuring of the database.
Database construction
The biological information regarding coagulation fac-
tors is scattered in many public domains and also cross-
linked with other databases [11–14]. Till date, there is 
no straightforward method to retrieve all the relevant 
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biological information regarding coagulation factors in 
one platform. CoagVDb offers all relevant information on 
genes, proteins and SAPs that are associated with bleed-
ing and coagulation disorders. Figure  1 illustrates the 
construction of the database. Major front end software 
components empowered in the database includes Html 
5.0, ASP.NET, and Microsoft Visual Studio 2010. The data 
information exported from the database is in Html 5.0 
and CS script format which allow users to display sup-
plementary information in a different web page. The web 
interface is designed using the interface ASP.NET and 
back-end data constructed using MS access 7.0. (Version 
2010).
Data source
We performed an exhaustive literature search for all the fac-
tors that are involved in the cascade pathway in Medline 
(http://www.nlm.nih.gov/bsd/pmresources.html) and Pub-
Med (http://www.ncbi.nlm.nih.gov/pubmed), by applying 
the search strings “Gene Name” and “Gene Name associ-
ated mutations”. A literature search was performed using 
the HGNC gene name. References listed in HGMD (http://
www.hgmd.cf.ac.uk/ac/index.php) and UniProt (http://
www.uniprot.org/) were cross-checked for the associated 
variants in coagulation disorders with reviewed publica-
tions. Medline contains indexed abstracts about coagulation 
factors. The OMIM provides curated literature information 
collected from the public accessed literature as well as other 
databases. Information related to a gene associated SAPs 
(rsIDs) was extracted from dbSNP (https://www.ncbi.nlm.
nih.gov/SNP/) and counter-checked with UniProt (variants) 
to maintain consistency. The inclusion of SAPs informa-
tion not only provides an overview of gene associated poly-
morphisms, but also provides the pathogenicity prediction 
scores for each SAP using various computational prediction 
methods.
Database structuring
The CoagVDb is composed of five sections namely gene 
information, variant information, sequence information, 
structure information, and tool prediction (Figure 1). The 
first section ‘gene information’ includes genes coding the 
factors, gene IDs, gene symbol, taxon IDs, nucleotide 
sequence, chromosome location, epigenetic information, 
and map viewer. The second section ‘variants informa-
tion’ consists of FASTA sequence, rs/Variant IDs, amino 
acid change and amino acid position. The third section 
‘sequence information’ composed of amino acid sequence, 
sequence length, amino acid composition, ordered and 
disordered regions, disulfide bond composition, second-
ary structure characteristics and solvent accessibility. 
The fourth section ‘structure information’ provides infor-
mation about the protein sequence IDs (NP), sequence 
length, and three-dimensional structures (3D). Also, we 
have included the information related to 3D coordinates 
such as experimental methods (NMR or X-Ray), resolu-
tion, chain type, and positions along with published lit-
erature. Last section ‘tool prediction’ contains prediction 
scores obtained for sequence and structure-based com-
putational methods such as SIFT, PolyPhen 2, I-Mutant 
3, fathmm, Align GVGD, PhD-SNP, SNPs&GO and SNAP 
to classify a variant as pathogenic and neutral.
Author’s contributions
SKA and DTK participated in literature search, data collection, analysis, and 
interpretation. SKA, CGPD, and DTK were involved in study design, data organi-
zation and construction of the database. HZ and CGPD supervised the entire 
study, participated in the study design, interpretation of the data and drafting 
of the manuscript. All authors read and approved the final manuscript.
Author details
1 Medical Biotechnology Division, School of Biosciences and Technology, VIT 
University, Vellore, Tamil Nadu 632014, India. 2 Department of Computer Sci-
ences, Hong Kong Baptist University, Kowloon Tong, Hong Kong. 
Acknowledgements
This work was supported by the Research Grants Council of Hong Kong 
(212111). Funding for Open Access Charge: Research Grants Council of Hong 
Kong/212111. The authors take this opportunity to thank the management of 
VIT University for providing the facilities and encouragement to carry out this 
work.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Received: 13 March 2015   Accepted: 10 July 2015
References
 1. Pruthi RK. A practical approach to genetic testing for von Willebrand 
disease. Mayo Clin Proc. 2006;81:679–91.
 2. Stefl S, Nishi H, Petukh M, Panchenko AR, Alexov E. Molecular 
mechanisms of disease-causing missense mutations. J Mol Biol. 
2013;425:3919–36.
 3. Yates CM, Sternberg MJ. The effects of non-synonymous single nucleo-
tide polymorphisms (nsSNPs) on protein-protein interactions. J Mol Biol. 
2013;425:3949–63.
 4. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server 
and survey. Nucleic Acids Res. 2002;30:3894–900.
 5. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, et al. 
The human gene mutation database: 2008 update. Genome Medicine. 
2009;1:13.
 6. Zhang Z, Miteva MA, Wang L, Alexov E. Analyzing effects of natu-
rally occurring missense mutations. Comput Math Methods Med. 
2012;2012:805827.
Additional file
Additional file 1. Table S1. Coagulation factor deficiencies and their 
prevalence in global population. Table S2. Detailed information regard-
ing computational methods employed in classifying SAPs as disease or 
neutral.
Page 8 of 8Ali et al. Biol Res  (2015) 48:35 
 7. Kucukkal TG, Yang Y, Chapman SC, Cao W, Alexov E. Computational 
and experimental approaches to reveal the effects of single nucleo-
tide polymorphisms with respect to disease diagnostics. Int J Mol Sci. 
2014;15:9670–717.
 8. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, et al. 
Database resources of the National Center for Biotechnology Information. 
Nucleic Acids Res. 2011;39:D38–51.
 9. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Chen Y, et al. Ensembl 2011. 
Nucleic Acids Res. 2011;39:D800–6.
 10. Amos B, Rolf A. The SWISS-PROT protein sequence data bank and its new 
supplement TREMBL. Nucleic Acids Res. 1996;24:21–5.
 11. Sonawani A, Nilawe P, Barai RS, Idicula-Thomas S. ClotBase: a knowledge-
base on proteins involved in blood coagulation. Blood. 2010;116:855–6.
 12. Rallapalli PM, Kemball-Cook G, Tuddenham EG, Gomez K, Perkins SJ 
(2014) Manuscript under Preparation. http://www.factorviii-db.org/
 13. Rallapalli PM, Kemball-Cook G, Tuddenham EG, Gomez K, Perkins SJ. An 
interactive mutation database for human coagulation factor IX provides 
novel insights into the phenotypes and genetics of haemophilia B. J. 
Thromb. 2013;11:1329–40.
 14. Hampshire DJ, Goodeve AC. The international society on thrombosis and 
haematosis von Willebrand disease database: an update. Semin Thromb 
Hemost. 2011;37:470–9.
 15. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synony-
mous variants on protein function using the SIFT algorithm. Nat Protoc. 
2009;4:1073–81.
 16. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, 
et al. A method and server for predicting damaging missense mutations. 
Nat Methods. 2010;7:248–9.
 17. Capriotti E, Fariselli P, Rossi I, Casadio R. A three-state prediction of single 
point mutations on protein stability changes. BMC Bioinform. 2008;9:S6.
 18. Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ, 
et al. Predicting the functional, molecular and phenotypic consequences 
of amino acid substitutions using hidden Markov models. Hum Mutat. 
2013;34:57–65.
 19. Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, 
et al. Comprehensive statistical study of 452 BRCA1 missense substitu-
tions with classification of eight recurrent substitutions as neutral. J Med 
Genet. 2006;43:295–305.
 20. Capriotti E, Calabrese R, Casadio R. Predicting the insurgence of human 
genetic diseases associated to single point protein mutations with 
support vector machines and evolutionary information. Bioinformatics. 
2006;22:2729–34.
 21. Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R. Functional anno-
tations improve the predictive score of human disease-related mutations 
in proteins. Hum Mutat. 2009;30:1237–44.
 22. Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymor-
phisms on function. Nucleic Acids Res. 2007;35:3823–35.
 23. Khan S, Vihinen M. Spectrum of disease-causing mutations in protein 
secondary structures. BMC Struct Biol. 2007;7:1–18.
 24. Dobson RJ, Munroe PB, Caulfield MJ, Saqi MA. Predicting deleterious 
nsSNPs: an analysis of sequence and structural attributes. BMC Bioinform. 
2006;7:217.
 25. Vitkup D, Sander C, Church G. The amino-acid mutational spectrum of 
human genetic disease. Genome Biol. 2003;4:R72.
 26. Brendel V, Bucher P, Nourbakhsh I. Blais- dell BE, Karlin S. Methods and 
algorithms for statistical analysis of protein sequences. Proc Natl Acad Sci 
USA. 1992;89:2002–6.
 27. Petersen B, Petersen TN, Andersen P, Nielsen M, Lundegaard C. A generic 
method for assignment of reliability scores applied to solvent accessibil-
ity predictions. BMC Struct Biol. 2009;9:51.
 28. Uversky VN, Oldfield CJ, Dunker AK. Showing your ID: intrinsic disorder 
as an ID for recognition, regulation and cell signaling. J Mol Recognit. 
2005;18:343–84.
 29. Cheng J, Sweredoski M, Baldi P. Accurate Prediction of Protein Disor-
dered Regions by Mining Protein Structure Data. Data Min Knowl Disc. 
2005;11:213–22.
 30. Song X, Geng Z, Zhu J, Li C, Hu X, Bian N, et al. Structure-function roles of 
four cysteine residues in the human arsenic (+3 oxidation state) methyl 
transferase (hAS3MT) by site directed mutagenesis. Chem Biol Interact. 
2009;179:321–8.
 31. Cheng J, Saigo H, Baldi P. Large-scale prediction of disulphide bridges 
using Kernel Methods, two-dimensional recursive neural networks, and 
weighted graph matching. Proteins. 2006;62:617–29.
 32. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein 
Function. Nucleic Acids Res. 2003;31:3812–4.
 33. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and 
high throughput. Nucleic Acids Res. 2004;32:1792–7.
 34. Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: calculat-
ing evolutionary conservation in sequence and structure of proteins and 
nucleic acids. Nucleic Acids Res. 2010;38:529–33.
 35. Kouranov A, Xie L, de la Cruz J, Chen L, Westbrook J, Bourne PE, et al. The 
RCSB PDB information portal for structural genomics. Nucleic Acids Res. 
2006;34:D302–5.
 36. Saunders RE, O’Connell NM, Lee CA, Perry DJ, Perkins SJ. Factor XI defi-
ciency database: an interactive web database of mutations, phenotypes, 
and structural analysis tools. Hum Mutat. 2005;26:192–8.
 37. Rallapalli PM, Kemball-Cook G, Tuddenham EG, Gomez K, Perkins SJ. An 
interactive mutation database for human coagulation factor IX provides 
novel insights into the phenotypes and genetics of haemophilia B. J 
Thromb Haemost. 2013;11:1329–40.
 38. Krawczak M, Ball EV, Fenton I, Stenson PD, Abeysinghe S, Thomas N, et al. 
Human gene mutation database-A biomedical information and research 
resource. Hum Mutat. 2000;15:45–51.
 39. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on 
protein function. Annu Rev Genomics Hum Genet. 2006;7:61–80.
 40. Chun S, Fay JC. Identification of deleterious mutations within three 
human genomes. Genome Res. 2009;19:1553–61.
 41. Wei Q, Wang L, Wang Q, Kruger WD, Dunbrack RL. Testing computational 
prediction of missense mutation phenotypes: functional characteriza-
tion of 204 mutations of human cystathionine beta synthase. Proteins. 
2010;78:2058–74.
 42. Thusberg J, Olatubosun A, Vihinen M. Performance of mutation 
pathogenicity prediction methods on missense variants. Hum Mutat. 
2011;32:358–68.
 43. Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, et al. Inter-
preting missense variants: comparing computational methods in human 
disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). Hum 
Mutat. 2007;28:683–93.
 44. Doss CGP. In silico profiling of deleterious amino acid substitutions of 
potential pathological importance in haemophlia A and haemophlia B. J 
Biomed Sci. 2012;19:30.
 45. George DC, Chakraborty C, Haneef SA, Nagasundaram N, Chen L, Zhu 
H. Evolution- and structure-based computational strategy reveals the 
impact of deleterious missense mutations on MODY 2 (maturity-onset 
diabetes of the young, type 2). Theranostics. 2014;4:366–85.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
